| | Human Health Effects of Ozone Depletion From Stratospheric |
| | 1,50 | | MB | Aircraft |
| | 138 | | stron |
| | 1076 | | ID | UNITED STATES ENVIRONMENTAL PROTECTION AGENCY |
| | 2001 | | rok |
| | Table of Contents |
| | Executive Summary 1 |
| | Chapter 1. Introduction and Background 11 |
| | 1.1 Potential atmospheric and biological impacts of stratospheric flight 11 |
| | 1.1.1 How HSCT may contribute to ozone depletion 11 |
| | 1.1.2 Current assessment of atmospheric impacts from stratospheric aircraft 12 |
| | 1.1.2.a. NASA’s Assessment of the Effects of High-Speed Aircraft in the Stratosphere. 13 |
| | 1.1.2.b. Aviation and the Global Atmosphere (IPCC 1999) 15 |
| | 1.1.3 Biological effects of stratospheric ozone depletion 16 |
| | 1.2 Relevant U.S. and international authorities and agencies 18 |
| | 1.2.1 U.S. Environmental Protection Agency (EPA) 18 |
| | 1.2.2 National Aeronautics and Space Administration (NASA) 20 |
| | 1.2.3 Federal Aviation Administration (FAA) 20 |
| | 1.2.4 International Civil Aviation Organization (ICAO) 21 |
| | 1.2.5 Montreal Protocol 22 |
| | 1.2.6 UN Framework Convention on Climate Change (UNFCCC) 23 |
| | 1.3 Commercial interest in supersonic technologies 25 |
| | 1.3.1 Civil supersonic transport 25 |
| | 1.3.2 Space and defense 26 |
| | 1.3.3 Supersonic business jets 26 |
| | Chapter 2. Methods 27 |
| | 2.1 Modeling overview 29 |
| | 2.2 Estimated HSCT-induced ozone change 31 |
| | 2.2.1 NASA assessment selection of source of central values 31 |
| | 2.2.2 Adaptation of CSIRO data and fleet growth schedule 32 |
| | 2.2.2.a. Adaptation of CSIRO data 32 |
| | 2.2.2.b. Specification of fleet growth schedule 34 |
| | 2.3 Calculation of UVR change 36 |
| | 2.4 Calculation of health impacts 38 |
| | 2.4.1 Human health endpoints 41 |
| | 2.4.2 Other human health and environmental effects 44 |
| | 2.4.3 Action spectra 45 |
| | 2.4.4 Dose metrics 47 |
| | 2.5 Model implementation 48 |
| | 2.6 Uncertainty in estimated impacts 49 |
| | 2.6.1 Uncertainties associated with change in ozone estimates 50 |
| | 2.6.2 Uncertainties associated with change in UVR estimates 53 |
| | 2.6.3 Uncertainties associated with change in health effect estimates 55 |
| | 2.6.3.a. Uncertainty in the BAF 55 |
| | 2.6.3.b. Uncertainty in population projections 55 |
| | 2.6.3.c. Latency 56 |
| | 2.6.4 Other sources of uncertainty 57 |
| | 2.6.4.a. Contributions to unknown uncertainties in change in ozone estimates 57 |
| | 2.6.4.b. Contributions to unknown uncertainties in change in health effect estimates 58 |
| | 2.7 Sensitivity of estimated health impacts to technological and operational change 60 |
| | Chapter 3. Results and Discussion 63 |
| | 3.1 HSCT impacts of stratospheric ozone concentrations 63 |
| | 3.1.1 Annual percent change in ozone 63 |
| | 3.1.2 Seasonal patterns 65 |
| | 3.1.3 Latitudinal patterns 67 |
| | 3.2 HSCT impacts on UVR 67 |
| | 3.2.1 Seasonal patterns 70 |
| | 3.2.2 Latitudinal patterns 70 |
| | 3.3 HSCT impacts on human health 70 |
| | 3.3.1 Total incidence and mortality due to HSCT operation 71 |
| | 3.3.2 Seasonal patterns 72 |
| | 3.3.3 Latitudinal patterns 73 |
| | 3.3.4 Estimates of annual changes in health effects 74 |
| | 3.4 Uncertainty analyses 79 |
| | 3.4.1 Uncertainties associated with change in ozone estimates 81 |
| | 3.4.2 Uncertainties associated with change in UVR estimates 81 |
| | 3.4.3 Uncertainties associated with change in health effects estimates 82 |
| | 3.4.3.a. Uncertainty in population projections 82 |
| | 3.4.3.b. Latency 83 |
| | 3.4.4 Summary of uncertainty analyses 85 |
| | 3.5 Sensitivity to technological and operational change 86 |
| | Chapter 4. Synthesis 89 |
| | 4.1 Findings in context of past ODS regulatory activities 89 |
| | 4.1.1 Description of the Montreal Protocol: Amendments and adjustments 89 |
| | 4.1.2 Comparison of HSCT with ODS policy scenarios 91 |
| | 4.1.3 Other stratospheric protection actions within and beyond |
| | Montreal Protocol requirements 95 |
| | 4.2 Applicability of results to other scenarios 97 |
| | Chapter 5. References 99 |
| | Appendix A - Overview of Evaluation Methodology 105 |
| | Appendix B - Description of the CSIRO Model 107 |
| | Appendix C - Methodological Sensitivity: Use of Relative Versus Absolute Ozone Change 109 |
| | Appendix D - Background Information on RAFs 111 |
| | Appendix E - Information and Future Directions for Cataract Methodology 115 |
| | Appendix F - Sensitivity to Choice of Reference Scenario 119 |
| | Appendix G - Summary of ODS Policy Controls 121 |